Rat MAU(Microalbuminuria) ELISA Kit
中文名称：大鼠尿微量白蛋白(MAU)酶联免疫吸附测定试剂盒
Price:
- 反应性： Rat
- 检测范围： 1.56-100 μg/mL
- 灵敏度： 0.94 μg/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗大鼠MAU抗体包被于酶标板上，实验时样品（或标准品）中的大鼠MAU会与包被抗体结合。后依次加入生物素化的抗大鼠MAU抗体和辣根过氧化物酶标记的亲和素，抗大鼠MAU抗体与结合在包被抗体上的大鼠MAU结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，MAU浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中MAU的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Rat |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 1.56-100 μg/mL |
| 灵敏度 | 0.94 μg/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的大鼠MAU，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis
IF: 3.100Journal： NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2024)Reactivity：RatSample Type：serum -
Effects of Zhuang medicine compound Xiancao Granules on diabetic kidney disease: A multi-omics analysis
IF: 5.400 -
Ephedra Herb extract ameliorates adriamycin-induced nephrotic syndrome in rats via the CAMKK2/AMPK/mTOR signaling pathway
IF: 4.600 -
Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy
IF: 3.800 -
Promising renoprotective effect of gold nanoparticles and dapagliflozin in diabetic nephropathy via targeting miR-192 and miR-21
IF: 3.600Journal： JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2023)PMID：37352119Reactivity：RatSample Type：urine -
Acacetin attenuates the pancreatic and hepatorenal dysfunction in type 2 diabetic rats induced by high-fat diet combined with streptozotocin
IF: 3.300 -
Epimedium sagittatum Maxim ameliorates adriamycin-induced nephropathy by restraining inflammation and apoptosis via the PI3K/AKT signaling pathway
IF: 3.200Journal： Immunity Inflammation and Disease (2023)DOI：10.1002/iid3.904PMID：37382268Reactivity：RatSample Type：urine -
Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2
IF: 2.800 -
Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis
IF: 2.700 -
Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5/6-nephrectomy
IF: 7.419
实验操作视频
